Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovering small-molecule therapeutics against SARS-CoV-2
Vaibhav Tiwari, Jacob C. Beer, Nehru Viji Sankaranarayanan, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 8, pp. 1535-1544
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
Damir Bojadzic, Óscar Garnica, Jinshui Chen, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 6, pp. 1519-1534
Open Access | Times Cited: 124
Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
Qingxin Li, CongBao Kang
Microorganisms (2020) Vol. 8, Iss. 8, pp. 1250-1250
Open Access | Times Cited: 121
Lactoferrin: an overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance
Michał Sienkiewicz, Andrzej Jaśkiewicz, Aleksandra Tarasiuk, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 22, pp. 6016-6033
Closed Access | Times Cited: 91
Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
Damir Bojadzic, Óscar Garnica, Péter Buchwald
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 90
Spike-heparan sulfate interactions in SARS-CoV-2 infection
Fiona L. Kearns, Daniel R. Sandoval, Lorenzo Casalino, et al.
Current Opinion in Structural Biology (2022) Vol. 76, pp. 102439-102439
Open Access | Times Cited: 69
Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro
Jingyi Yang, Xiaoyuan Lin, Na Xing, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 8, pp. 3917-3926
Closed Access | Times Cited: 66
Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer
Vaibhav Tiwari, Raghuram Koganti, Greer Russell, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2
Valeria De Pasquale, Miriam Shasa Quiccione, Simona Tafuri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6574-6574
Open Access | Times Cited: 62
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
Magnus S. Bauer, Sophia Gruber, Adina Hausch, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 14
Open Access | Times Cited: 52
Advancements in the development of antivirals against SARS-Coronavirus
Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access | Times Cited: 1
Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein
Giuseppe Deganutti, Filippo Prischi, Christopher A. Reynolds
Journal of Computer-Aided Molecular Design (2020) Vol. 35, Iss. 2, pp. 195-207
Open Access | Times Cited: 53
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
Jingwen Yue, Weihua Jin, Hyun Mo Yang, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 51
Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures
Martina Zafferani, Christina Haddad, Le Luo, et al.
Science Advances (2021) Vol. 7, Iss. 48
Open Access | Times Cited: 49
Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics
Ran Chen, Tingting Wang, Jie Song, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4959-4984
Open Access | Times Cited: 43
COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
Wei Shen Ho, Ruirui Zhang, Yeong Lan Tan, et al.
Pharmacological Research (2022) Vol. 179, pp. 106201-106201
Open Access | Times Cited: 30
Natural and Nature-Derived Products Targeting Human Coronaviruses
Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 448-448
Open Access | Times Cited: 34
Research progress of biosensors for detection of SARS-CoV-2 variants based on ACE2
Hongshuai Wei, Congcong Zhang, Xin Du, et al.
Talanta (2022) Vol. 251, pp. 123813-123813
Open Access | Times Cited: 24
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics
Matteo Pavan, Stefano Moro
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4401-4401
Open Access | Times Cited: 14
Significance of Artificial Intelligence in the Study of Virus–Host Cell Interactions
James Elste, Akash Saini, Rafael Mejía-Alvarez, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 911-911
Open Access | Times Cited: 5
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 36
On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein
John E. Chittum, Nehru Viji Sankaranarayanan, Connor P. O’Hara, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 11, pp. 1710-1717
Open Access | Times Cited: 28
Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis
Israël Vlodavsky, Uri Barash, Hien M. Nguyen, et al.
Seminars in Thrombosis and Hemostasis (2021) Vol. 47, Iss. 03, pp. 240-253
Open Access | Times Cited: 24
Intracellular mono-ADP-ribosyltransferases at the host–virus interphase
Bernhard Lüscher, Maud Verheirstraeten, Sarah Krieg, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 18
Role of structure-based drug design (SBDD) in the repurposing and discovery of anti-viral leads against Monkeypox virus disease
Jihane Touhtouh, Fettouma Chraa, Doha El Meskini, et al.
Results in Chemistry (2025), pp. 102317-102317
Open Access
Identification of an Unnatural Sulfated Monosaccharide as a High-Affinity Ligand for Pan-Variant Targeting of SARS-CoV-2 Spike Glycoprotein
A.Ronald Thompson, Nehru Viji Sankaranarayanan, John E. Chittum, et al.
ACS Chemical Biology (2025)
Open Access
Page 1 - Next Page

Scroll to top